Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycleFrançois Lamoureux(Inserm), Benjamin Ory(Inserm)Nature CommunicationsMarch 19, 201410.1038/ncomms4511Cited by 145SaveCiteExport RISWatch citationsRelated PapersTargeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1|Oncotarget|2016|50TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model|EBioMedicine|2020|36Tracking Targets of Dynamic Super-Enhancers <i>in Vitro</i> to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells|Environmental Health Perspectives|2023|5